Frontlight ResearchEarly access
Trial site
National University Cancer Institute
- 5running trials
- 3closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Myelodysplastic syndromes3 trials
- Acute lymphoblastic leukaemia2 trials
- Childhood cancers2 trials
- Chronic myeloid leukaemia2 trials
- Head and neck cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- Lung cancer1 trial
- Multiple myeloma1 trial
- Myeloproliferative neoplasms1 trial
- Ovarian cancer1 trial
- Phase
- Phase 24 trials
- Phase 32 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- ALX Oncology Inc.2 trials
- Eli Lilly and Company1 trial
- EMD Serono Research & Development Institute, Inc.1 trial
- Gamida Cell ltd1 trial
- Sumitomo Pharma America, Inc.1 trial
- and 2 more
Running trials
Recruiting
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026